These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep. Lorenzo G, Martín-Folgar R, Rodríguez F, Brun A. Vaccine; 2008 Sep 26; 26(41):5255-62. PubMed ID: 18682268 [Abstract] [Full Text] [Related]
25. Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep. Harrington DG, Lupton HW, Crabbs CL, Peters CJ, Reynolds JA, Slone TW. Am J Vet Res; 1980 Oct 26; 41(10):1559-64. PubMed ID: 7224281 [Abstract] [Full Text] [Related]
30. Safety and immunogenicity of Onderstepoort Biological Products' Rift Valley fever Clone 13 vaccine in sheep and goats under field conditions in Senegal. Lo MM, Mbao V, Sierra P, Thiongane Y, Diop M, Donadeu M, Dungu B. Onderstepoort J Vet Res; 2015 May 29; 82(1):857. PubMed ID: 26244679 [Abstract] [Full Text] [Related]
31. Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine. Soi RK, Rurangirwa FR, McGuire TC, Rwambo PM, DeMartini JC, Crawford TB. Clin Vaccine Immunol; 2010 Dec 29; 17(12):1842-9. PubMed ID: 20876822 [Abstract] [Full Text] [Related]
32. Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments. Ikegami T, Hill TE, Smith JK, Zhang L, Juelich TL, Gong B, Slack OA, Ly HJ, Lokugamage N, Freiberg AN. J Virol; 2015 Jul 29; 89(14):7262-76. PubMed ID: 25948740 [Abstract] [Full Text] [Related]
33. Rift Valley fever MP-12 vaccine elicits an early protective immune response in mice. Morrill JC, Peters CJ, Bettinger GE, Palermo PM, Smith DR, Watts DM. Vaccine; 2022 Nov 28; 40(50):7255-7261. PubMed ID: 36333222 [Abstract] [Full Text] [Related]
34. Evaluation of an Indirect Enzyme-Linked Immunosorbent Assay Based on Recombinant Baculovirus-Expressed Rift Valley Fever Virus Nucleoprotein as the Diagnostic Antigen. Faburay B, Wilson WC, Secka A, Drolet B, McVey DS, Richt JA. J Clin Microbiol; 2019 Oct 28; 57(10):. PubMed ID: 31366690 [Abstract] [Full Text] [Related]
35. Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain. Ly HJ, Nishiyama S, Lokugamage N, Smith JK, Zhang L, Perez D, Juelich TL, Freiberg AN, Ikegami T. Vaccine; 2017 Dec 04; 35(48 Pt B):6634-6642. PubMed ID: 29061350 [Abstract] [Full Text] [Related]
36. Modelling Vaccination Strategies against Rift Valley Fever in Livestock in Kenya. Gachohi JM, Njenga MK, Kitala P, Bett B. PLoS Negl Trop Dis; 2016 Dec 04; 10(12):e0005049. PubMed ID: 27973528 [Abstract] [Full Text] [Related]
37. Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice. Prajeeth CK, Zdora I, Saletti G, Friese J, Gerlach T, Wilken L, Beicht J, Kubinski M, Puff C, Baumgärtner W, Kortekaas J, Wichgers Schreur PJ, Osterhaus ADME, Rimmelzwaan GF. Emerg Microbes Infect; 2024 Dec 04; 13(1):2373313. PubMed ID: 38946528 [Abstract] [Full Text] [Related]